A Study of PN20 for the Prevention of Chemotherapy-induced Thrombocytopenia in Lymphoma or Solid Tumor Patients
Chongqing Peg-Bio Biopharm Co., Ltd.
Chongqing Peg-Bio Biopharm Co., Ltd.
Zhejiang Cancer Hospital
National Institutes of Health Clinical Center (CC)
Boston Children's Hospital
Centre Henri Becquerel
Ottawa Hospital Research Institute
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
M.D. Anderson Cancer Center
Dartmouth-Hitchcock Medical Center
Hebei Medical University Fourth Hospital
Case Comprehensive Cancer Center
Assiut University
Centre Hospitalier Universitaire de Besancon
Hospices Civils de Lyon
Thomas Jefferson University
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Beth Israel Deaconess Medical Center
University of Utah
Centre Hospitalier Annecy Genevois
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Mario Negri Institute for Pharmacological Research
Peking University Cancer Hospital & Institute
Mount Sinai Hospital, Canada
Fudan University
Memorial Sloan Kettering Cancer Center
Sobi, Inc.
M.D. Anderson Cancer Center
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Cairo University
Örebro University, Sweden
OHSU Knight Cancer Institute
Cellphire Therapeutics, Inc.
M.D. Anderson Cancer Center
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Novartis
Fundació Sant Joan de Déu
Emory University
Celgene
Celgene
University of Utah
Anhui Provincial Cancer Hospital
Shanghai Zhongshan Hospital
Terumo BCTbio
Peking Union Medical College Hospital
Groupe Francophone des Myelodysplasies
Sun Yat-sen University
City of Hope Medical Center
PrECOG, LLC.
National Institutes of Health Clinical Center (CC)
CTI BioPharma